Finally, FXR can regulate the balance of relaxation and contraction in smooth muscle cells by reducing the conduction of the NO-sGC-cGMP signaling pathway, which in turn normalizes the function of pulmonary vascular endothelium and thus inhibits the progression of PAH. This evidence concerns the gene NR1H4 and pulmonary arterial hypertension.